146 related articles for article (PubMed ID: 38127222)
1. Performance evaluate of different chemometrics formalisms used for prostate cancer diagnosis by NMR-based metabolomics.
Oliveira MF; de Albuquerque Neto MC; Leite TS; Alves PAA; Lima SVC; Silva RO
Metabolomics; 2023 Dec; 20(1):8. PubMed ID: 38127222
[TBL] [Abstract][Full Text] [Related]
2. NMR metabolomic profiles associated with long-term risk of prostate cancer.
Lécuyer L; Victor Bala A; Demidem A; Rossary A; Bouchemal N; Triba MN; Galan P; Hercberg S; Partula V; Srour B; Latino-Martel P; Kesse-Guyot E; Druesne-Pecollo N; Vasson MP; Deschasaux-Tanguy M; Savarin P; Touvier M
Metabolomics; 2021 Mar; 17(3):32. PubMed ID: 33704614
[TBL] [Abstract][Full Text] [Related]
3. Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data.
Grissa D; Pétéra M; Brandolini M; Napoli A; Comte B; Pujos-Guillot E
Front Mol Biosci; 2016; 3():30. PubMed ID: 27458587
[TBL] [Abstract][Full Text] [Related]
4. Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models.
Khalvati F; Wong A; Haider MA
BMC Med Imaging; 2015 Aug; 15():27. PubMed ID: 26242589
[TBL] [Abstract][Full Text] [Related]
5. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
Kumar D; Gupta A; Mandhani A; Sankhwar SN
Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of patients with and without prostate cancer using urine
Hasubek AL; Wang X; Zhang E; Kobus M; Chen J; Vandergrift LA; Kurreck A; Ehret F; Dinges S; Hohm A; Tilgner M; Buko A; Habbel P; Nowak J; Mercaldo ND; Gusev A; Feldman AS; Cheng LL
Magn Reson Chem; 2023 Dec; 61(12):740-747. PubMed ID: 37654196
[TBL] [Abstract][Full Text] [Related]
7. NMR-based metabolomics studies of human prostate cancer tissue.
Lima AR; Pinto J; Bastos ML; Carvalho M; Guedes de Pinho P
Metabolomics; 2018 Jun; 14(7):88. PubMed ID: 30830350
[TBL] [Abstract][Full Text] [Related]
8. A decade in prostate cancer: from NMR to metabolomics.
DeFeo EM; Wu CL; McDougal WS; Cheng LL
Nat Rev Urol; 2011 May; 8(6):301-11. PubMed ID: 21587223
[TBL] [Abstract][Full Text] [Related]
9. Optimal preprocessing of serum and urine metabolomic data fusion for staging prostate cancer through design of experiment.
Zheng H; Cai A; Zhou Q; Xu P; Zhao L; Li C; Dong B; Gao H
Anal Chim Acta; 2017 Oct; 991():68-75. PubMed ID: 29031300
[TBL] [Abstract][Full Text] [Related]
10. Metabolomic biomarkers in cervicovaginal fluid for detecting endometrial cancer through nuclear magnetic resonance spectroscopy.
Cheng SC; Chen K; Chiu CY; Lu KY; Lu HY; Chiang MH; Tsai CK; Lo CJ; Cheng ML; Chang TC; Lin G
Metabolomics; 2019 Oct; 15(11):146. PubMed ID: 31664624
[TBL] [Abstract][Full Text] [Related]
11. Distinct Metabolic Signatures of Hormone-Sensitive and Castration-Resistant Prostate Cancer Revealed by a
Zheng H; Zhu Y; Shao X; Cai A; Dong B; Xue W; Gao H
J Proteome Res; 2020 Sep; 19(9):3741-3749. PubMed ID: 32702989
[TBL] [Abstract][Full Text] [Related]
12. Robustness of chemometrics-based feature selection methods in early cancer detection and biomarker discovery.
Lee HW; Lawton C; Na YJ; Yoon S
Stat Appl Genet Mol Biol; 2013 Mar; 12(2):207-23. PubMed ID: 23502343
[TBL] [Abstract][Full Text] [Related]
13. New findings on urinary prostate cancer metabolome through combined GC-MS and
Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
[TBL] [Abstract][Full Text] [Related]
14. Predicting Positive Repeat Prostate Biopsy Outcomes: Comparison of Machine Learning Approaches to Identify Key Parameters and Optimal Algorithms.
Zhang X; Feng C; Bai X; Peng X; Guo Q; Chen L; Xue J
Arch Esp Urol; 2023 Sep; 76(7):494-503. PubMed ID: 37867334
[TBL] [Abstract][Full Text] [Related]
15. GIPMA: Global Intensity-Guided Peak Matching and Alignment for 2D
Du H; Gu X; Chen J; Bai C; Duan X; Hu K
Anal Chem; 2023 Feb; 95(6):3195-3203. PubMed ID: 36728684
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia-osteoporosis discrimination in postmenopausal women by 1H NMR-based metabonomics.
Pontes TA; Barbosa AD; Silva RD; Melo-Junior MR; Silva RO
PLoS One; 2019; 14(5):e0217348. PubMed ID: 31141566
[TBL] [Abstract][Full Text] [Related]
17. Comparing normalization methods and the impact of noise.
Vu T; Riekeberg E; Qiu Y; Powers R
Metabolomics; 2018 Aug; 14(8):108. PubMed ID: 30830388
[TBL] [Abstract][Full Text] [Related]
18. Identification of characteristic metabolic panels for different stages of prostate cancer by
Zhang X; Xia B; Zheng H; Ning J; Zhu Y; Shao X; Liu B; Dong B; Gao H
J Transl Med; 2022 Jun; 20(1):275. PubMed ID: 35715864
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics-derived prostate cancer biomarkers: fact or fiction?
Kumar D; Gupta A; Mandhani A; Sankhwar SN
J Proteome Res; 2015 Mar; 14(3):1455-64. PubMed ID: 25609016
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
